The starting dose of compounded tirzepatide is typically low, with gradual titration upward based on your response and tolerance
Clinical reports on GLP-1 therapies show that, for many people with PCOS, improved insulin control and weight reduction often lead to more regular periods, underscoring that the direction of change depends on baseline metabolic status
Why it matters: Rising use of GLP-1s is having a broader impact on multiple industries, including healthcare and pharma, apparel retailers, and consumer packaged goods
This is a common question for anyone who wants to ensure they are getting the most out of their wellness investment
It tells you nothing about how much tirzepatide you are actually getting
Before joining MedExpress, I built experience in clinical operations and digital health through leadership roles at Kry/Livi and Numan